In addition to the confirmation of the well-known detrimental outcome for patients harboring a TP53 abnormality, we report for the first time a similar dismal prognosis for patients with PTPN11 mutations in AML with abn(7). This evidence concerns the gene TP53 and acute myeloid leukemia.